Konstantinos Xynos Replimune Group, Inc. (REPL) insider trading activity

Konstantinos Xynos is Chief Medical Officer of Replimune Group, Inc.. Currently has a direct ownership of 109,885 shares of REPL, which is worth approximately $1.37 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 7,246 shares (Common Stock) at a price of $10.78 per share, resulting in proceeds of $78,111. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

6.19% 3M change

2.51% 12M change

Total Value Held $1.37 Million

Konstantinos Xynos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Open market or private sale	$78,111 $10.78 p/Share	7,246 Reduced 6.19%	109,885 Common Stock
Jun 07 2024	SELL Open market or private sale	$119,107 $7.5 p/Share	15,881 Reduced 11.94%	117,131 Common Stock
May 16 2024	SELL Open market or private sale	$41,194 $6.47 p/Share	6,367 Reduced 4.57%	133,012 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	26,665 Added 16.06%	139,379 Common Stock
Nov 16 2023	SELL Open market or private sale	$79,857 $10.92 p/Share	7,313 Reduced 6.09%	112,714 Common Stock
May 16 2023	SELL Open market or private sale	$13,916 $18.05 p/Share	771 Reduced 0.64%	120,027 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	50,000 Added 29.27%	120,798 Common Stock
Dec 01 2022	BUY Grant, award, or other acquisition	-	17,500 Added 19.82%	70,798 Common Stock

Konstantinos Xynos

Chief Medical Officer

Woburn, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Value

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL

Account